115 related articles for article (PubMed ID: 8226934)
1. Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA.
Lawrence DL; Engelsberg BN; Farid RS; Hughes EN; Billings PC
J Biol Chem; 1993 Nov; 268(32):23940-5. PubMed ID: 8226934
[TBL] [Abstract][Full Text] [Related]
2. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.
Farid RS; Bianchi ME; Falciola L; Engelsberg BN; Billings PC
Toxicol Appl Pharmacol; 1996 Dec; 141(2):532-9. PubMed ID: 8975778
[TBL] [Abstract][Full Text] [Related]
3. Characterization of high mobility group protein binding to cisplatin-damaged DNA.
Billings PC; Davis RJ; Engelsberg BN; Skov KA; Hughes EN
Biochem Biophys Res Commun; 1992 Nov; 188(3):1286-94. PubMed ID: 1445361
[TBL] [Abstract][Full Text] [Related]
4. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2.
Hughes EN; Engelsberg BN; Billings PC
J Biol Chem; 1992 Jul; 267(19):13520-7. PubMed ID: 1618852
[TBL] [Abstract][Full Text] [Related]
5. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
Chow CS; Barnes CM; Lippard SJ
Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin.
Cryer JE; Johnson SW; Engelsberg BN; Billings PC
Cancer Chemother Pharmacol; 1996; 38(2):163-8. PubMed ID: 8616907
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein.
Turchi JJ; Li M; Henkels KM
Biochemistry; 1996 Mar; 35(9):2992-3000. PubMed ID: 8608137
[TBL] [Abstract][Full Text] [Related]
8. Proteins binding to cisplatin-damaged DNA in human cell lines.
Billings PC; Engelsberg BN; Hughes EN
Cancer Invest; 1994; 12(6):597-604. PubMed ID: 7994594
[TBL] [Abstract][Full Text] [Related]
9. Dual function of Ixr1 in transcriptional regulation and recognition of cisplatin-DNA adducts is caused by differential binding through its two HMG-boxes.
Vizoso-Vázquez A; Lamas-Maceiras M; Fernández-Leiro R; Rico-Díaz A; Becerra M; Cerdán ME
Biochim Biophys Acta Gene Regul Mech; 2017 Feb; 1860(2):256-269. PubMed ID: 27871851
[TBL] [Abstract][Full Text] [Related]
10. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
[TBL] [Abstract][Full Text] [Related]
11. Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin.
Chao JC; Wan XS; Engelsberg BN; Rothblum LI; Billings PC
Biochim Biophys Acta; 1996 Jun; 1307(2):213-9. PubMed ID: 8679707
[TBL] [Abstract][Full Text] [Related]
12. Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin.
Yarnell AT; Oh S; Reinberg D; Lippard SJ
J Biol Chem; 2001 Jul; 276(28):25736-41. PubMed ID: 11344167
[TBL] [Abstract][Full Text] [Related]
13. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-DNA damage recognition proteins in human tumour extracts.
Bissett D; McLaughlin K; Kelland LR; Brown R
Br J Cancer; 1993 Apr; 67(4):742-8. PubMed ID: 8471431
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells.
Arioka H; Nishio K; Ishida T; Fukumoto H; Fukuoka K; Nomoto T; Kurokawa H; Yokote H; Abe S; Saijo N
Jpn J Cancer Res; 1999 Jan; 90(1):108-15. PubMed ID: 10076573
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.
Patrick SM; Henkels KM; Turchi JJ
Biochim Biophys Acta; 1997 Nov; 1354(3):279-90. PubMed ID: 9427537
[TBL] [Abstract][Full Text] [Related]
17. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
Stros M
Biochemistry; 2001 Apr; 40(15):4769-79. PubMed ID: 11294645
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase CK2 phosphorylates the high mobility group domain protein SSRP1, inducing the recognition of UV-damaged DNA.
Krohn NM; Stemmer C; Fojan P; Grimm R; Grasser KD
J Biol Chem; 2003 Apr; 278(15):12710-5. PubMed ID: 12571244
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin.
Bruhn SL; Pil PM; Essigmann JM; Housman DE; Lippard SJ
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2307-11. PubMed ID: 1372440
[TBL] [Abstract][Full Text] [Related]
20. Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism.
Locker D; Decoville M; Maurizot JC; Bianchi ME; Leng M
J Mol Biol; 1995 Feb; 246(2):243-7. PubMed ID: 7869375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
